AXT Soars Again on Monday to Lead Optics Stocks. Coherent and Lumentum Rally on Indium Phosphide Price Hikes
Optics stocks rose Monday on reports of severe undersupply and price hikes for indium phosphide (InP) substrates and epitaxial wafers, with Q4 increases cited as more than 10%. AXT (AXTI) was up 13.7% to $92.83; Coherent (COHR) up 8.1%; Lumentum (LITE) up 6.8%. AXT cited prior record InP revenue and capacity targets; Coherent and Lumentum discussed InP capacity expansion and substrate sourcing.
How this was made
The 30-second read
Why it matters
It frames AXT as the supply-side read-through and Coherent and Lumentum as demand-side beneficiaries that are ramping internal InP capacity and sourcing substrates from AXT, with management guidance cited for near-term revenue.
Market read
Traders can use the InP pricing report as a same-day driver for optics/photonic names with InP exposure, especially AXT, COHR, and LITE.
What to watch
The catalyst is a report about supply and pricing; without confirmed contract pricing or purchase orders, the magnitude and timing of margin impact could be overstated.
Background
The article attributes Monday’s rally in optics stocks to a Taipei report describing severe undersupply in indium phosphide substrates and epitaxial wafers, with Q4 price increases above 10%.
Ticker impact
AXTI is cited as the InP price read-through after a Taipei report says Q4 indium phosphide substrate and epitaxial wafer prices rise over 10%.
Bullish near-term bias as traders price in higher InP substrate pricing and constrained supply.
The piece provides a concrete catalyst (UDN Taipei InP pricing report) and ties it to AXT’s InP revenue/margins and capacity targets, but it is still a secondary report rather than a company filing.
Coherent is described as building internal InP capacity and buying AXT substrate, with management guidance for fiscal Q1 revenue of $2.2B to $2.4B.
Likely continued momentum if the market believes InP availability and VR200 ramp translate into higher revenue.
The article includes specific management statements and guidance, but the core catalyst is the InP pricing report, not a new Coherent-specific disclosure.
Lumentum flags additional substrate help from AXTI and guides Q1 revenue to about $1.25B, while the article links the move to InP price hikes.
Positive bias for follow-through given the stated AXTI substrate partnership and strong Q4 metrics.
The article provides concrete company-level quotes and guidance, but it is still a theme-driven rally anchored to an external supply report.
Market effects
Supports a broader optics and photonics trade where InP substrate scarcity can lift both supply-side margins and demand-side output ramps.
Taipei-sourced supply tightness narrative can spill into US-listed optics equities via read-through trading.
InP is linked to AI data-center photonics; the article frames the squeeze as an AI infrastructure tailwind.
Counterpoint
Price hikes may not fully translate into earnings if customers cannot secure supply or if higher substrate costs compress margins for downstream users.
Key entities
- public_companyAXT
US-listed InP substrate producer described as the direct read-through to indium phosphide price hikes.
- public_companyCoherent
Optics company building internal InP capacity and buying InP substrates, with fiscal Q1 revenue guidance cited.
- public_companyLumentum
Optics company citing additional substrate help from AXTI and providing Q1 revenue guidance.
- commodity_inputIndium phosphide (InP) substrates
The constrained input whose reported Q4 price increases are presented as the proximate catalyst.
